Examination of Low ERBB2 Protein Expression in Breast Cancer TissueAileen I. Fernandez, David L. Rimm, Matthew Liu et al.|JAMA Oncology|2022Cited by 347
Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineagesJennifer M. Rosenbluth, Joan S. Brugge, Ron C.J. Schackmann et al.|Nature Communications|2020Cited by 273
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G. Stover, Nancy U. Lin, Yaomin Xu et al.|npj Breast Cancer|2018Cited by 150
The Immune Microenvironment in Hormone Receptor–Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G. Waks, Sara M. Tolaney, Daniel G. Stover et al.|Clinical Cancer Research|2019Cited by 118
Multi-institutional Assessment of Pathologist Scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Modern Pathology|2023Cited by 98